(3S)-3-(4-chlorophenyl)-N-[(2S)-2-(dimethylamino)-3-[1-(4-methylphenyl)sulfonylindazol-5-yl]propyl]butanamide

C29H33ClN4O3S — CID 166025534

IUPAC(3S)-3-(4-chlorophenyl)-N-[(2S)-2-(dimethylamino)-3-[1-(4-methylphenyl)sulfonylindazol-5-yl]propyl]butanamide
SMILESCc1ccc(S(=O)(=O)n2ncc3cc(C[C@@H](CNC(=O)C[C@H](C)c4ccc(Cl)cc4)N(C)C)ccc32)cc1
InChIInChI=1S/C29H33ClN4O3S/c1-20-5-12-27(13-6-20)38(36,37)34-28-14-7-22(16-24(28)18-32-34)17-26(33(3)4)19-31-29(35)15-21(2)23-8-10-25(30)11-9-23/h5-14,16,18,21,26H,15,17,19H2,1-4H3,(H,31,35)/t21-,26-/m0/s1
InChIKeyQVIPZQLCYHFWRX-LVXARBLLSA-N
MW553.13 g/mol
LogP5.02
Rot. Bonds10

About (3S)-3-(4-chlorophenyl)-N-[(2S)-2-(dimethylamino)-3-[1-(4-methylphenyl)sulfonylindazol-5-yl]propyl]butanamide

(3S)-3-(4-chlorophenyl)-N-[(2S)-2-(dimethylamino)-3-[1-(4-methylphenyl)sulfonylindazol-5-yl]propyl]butanamide (PubChem CID 166025534) has the molecular formula C29H33ClN4O3S and a molecular weight of 553.13 g/mol. Its IUPAC name is (3S)-3-(4-chlorophenyl)-N-[(2S)-2-(dimethylamino)-3-[1-(4-methylphenyl)sulfonylindazol-5-yl]propyl]butanamide.

Molecular Properties

Compound Name(3S)-3-(4-chlorophenyl)-N-[(2S)-2-(dimethylamino)-3-[1-(4-methylphenyl)sulfonylindazol-5-yl]propyl]butanamide
PubChem CID166025534
Molecular FormulaC29H33ClN4O3S
Molecular Weight553.13 g/mol
Exact Mass552.20
IUPAC Name(3S)-3-(4-chlorophenyl)-N-[(2S)-2-(dimethylamino)-3-[1-(4-methylphenyl)sulfonylindazol-5-yl]propyl]butanamide
SMILESCc1ccc(S(=O)(=O)n2ncc3cc(C[C@@H](CNC(=O)C[C@H](C)c4ccc(Cl)cc4)N(C)C)ccc32)cc1
InChIInChI=1S/C29H33ClN4O3S/c1-20-5-12-27(13-6-20)38(36,37)34-28-14-7-22(16-24(28)18-32-34)17-26(33(3)4)19-31-29(35)15-21(2)23-8-10-25(30)11-9-23/h5-14,16,18,21,26H,15,17,19H2,1-4H3,(H,31,35)/t21-,26-/m0/s1
InChIKeyQVIPZQLCYHFWRX-LVXARBLLSA-N
XLogP5.02
TPSA84.30 Ų
H-Bond Donors1
H-Bond Acceptors6
Rotatable Bonds10
Heavy Atoms38
Complexity—

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500553.13
LogP ≤ 55.02
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 106

Analyze (3S)-3-(4-chlorophenyl)-N-[(2S)-2-(dimethylamino)-3-[1-(4-methylphenyl)sulfonylindazol-5-yl]propyl]butanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (3S)-3-(4-chlorophenyl)-N-[(2S)-2-(dimethylamino)-3-[1-(4-methylphenyl)sulfonylindazol-5-yl]propyl]butanamide?
The IUPAC name of (3S)-3-(4-chlorophenyl)-N-[(2S)-2-(dimethylamino)-3-[1-(4-methylphenyl)sulfonylindazol-5-yl]propyl]butanamide (CID 166025534) is (3S)-3-(4-chlorophenyl)-N-[(2S)-2-(dimethylamino)-3-[1-(4-methylphenyl)sulfonylindazol-5-yl]propyl]butanamide.
What is the SMILES notation for (3S)-3-(4-chlorophenyl)-N-[(2S)-2-(dimethylamino)-3-[1-(4-methylphenyl)sulfonylindazol-5-yl]propyl]butanamide?
The canonical SMILES for (3S)-3-(4-chlorophenyl)-N-[(2S)-2-(dimethylamino)-3-[1-(4-methylphenyl)sulfonylindazol-5-yl]propyl]butanamide is Cc1ccc(S(=O)(=O)n2ncc3cc(C[C@@H](CNC(=O)C[C@H](C)c4ccc(Cl)cc4)N(C)C)ccc32)cc1.
What is the InChIKey of (3S)-3-(4-chlorophenyl)-N-[(2S)-2-(dimethylamino)-3-[1-(4-methylphenyl)sulfonylindazol-5-yl]propyl]butanamide?
The InChIKey is QVIPZQLCYHFWRX-LVXARBLLSA-N. The full InChI is InChI=1S/C29H33ClN4O3S/c1-20-5-12-27(13-6-20)38(36,37)34-28-14-7-22(16-24(28)18-32-34)17-26(33(3)4)19-31-29(35)15-21(2)23-8-10-25(30)11-9-23/h5-14,16,18,21,26H,15,17,19H2,1-4H3,(H,31,35)/t21-,26-/m0/s1.
What are the key properties of (3S)-3-(4-chlorophenyl)-N-[(2S)-2-(dimethylamino)-3-[1-(4-methylphenyl)sulfonylindazol-5-yl]propyl]butanamide?
(3S)-3-(4-chlorophenyl)-N-[(2S)-2-(dimethylamino)-3-[1-(4-methylphenyl)sulfonylindazol-5-yl]propyl]butanamide has a molecular weight of 553.13 g/mol, XLogP of 5.02, 10 rotatable bonds, 1 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for (3S)-3-(4-chlorophenyl)-N-[(2S)-2-(dimethylamino)-3-[1-(4-methylphenyl)sulfonylindazol-5-yl]propyl]butanamide is sourced from PubChem (CID 166025534), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).